These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8254656)

  • 41. Prediction of the secondary structure and functional sites of major histocompatibility complex molecules.
    Fraga S; San-Fabian E; Thornton S; Singh B
    J Mol Recognit; 1990 Apr; 3(2):65-73. PubMed ID: 1694447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The importance of extended conformations and, in particular, the PII conformation for the molecular recognition of peptides.
    Siligardi G; Drake AF
    Biopolymers; 1995; 37(4):281-92. PubMed ID: 7540055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.
    Zhang W; Young AC; Imarai M; Nathenson SG; Sacchettini JC
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8403-7. PubMed ID: 1325657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle.
    Guo HC; Jardetzky TS; Garrett TP; Lane WS; Strominger JL; Wiley DC
    Nature; 1992 Nov; 360(6402):364-6. PubMed ID: 1448153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Automatic sequence design of major histocompatibility complex class I binding peptides impairing CD8+ T cell recognition.
    Ogata K; Jaramillo A; Cohen W; Briand JP; Connan F; Choppin J; Muller S; Wodak SJ
    J Biol Chem; 2003 Jan; 278(2):1281-90. PubMed ID: 12411444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling the structure of bound peptide ligands to major histocompatibility complex.
    Tong JC; Tan TW; Ranganathan S
    Protein Sci; 2004 Sep; 13(9):2523-32. PubMed ID: 15322290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.
    Corr M; Boyd LF; Frankel SR; Kozlowski S; Padlan EA; Margulies DH
    J Exp Med; 1992 Dec; 176(6):1681-92. PubMed ID: 1281216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.
    Bouvier M; Wiley DC
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4583-8. PubMed ID: 8643447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.
    Fremont DH; Matsumura M; Stura EA; Peterson PA; Wilson IA
    Science; 1992 Aug; 257(5072):919-27. PubMed ID: 1323877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CH/pi interactions in the crystal structure of class I MHC antigens and their complexes with peptides.
    Umezawa Y; Nishio M
    Bioorg Med Chem; 1998 Dec; 6(12):2507-15. PubMed ID: 9925306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monte Carlo study of the effect of beta 2-microglobulin on the binding cleft of the HLA-A2 complex.
    Bouzida D; Garnier J; Brower R; Cornette J; DeLisi C
    Protein Sci; 1994 Jun; 3(6):911-9. PubMed ID: 8069222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flexible docking of peptides to class I major-histocompatibility-complex receptors.
    Rosenfeld R; Zheng Q; Vajda S; DeLisi C
    Genet Anal; 1995 Mar; 12(1):1-21. PubMed ID: 7648466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from influenza virus matrix protein.
    Rognan D; Zimmermann N; Jung G; Folkers G
    Eur J Biochem; 1992 Aug; 208(1):101-13. PubMed ID: 1511679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toward computational determination of peptide-receptor structure.
    Sezerman U; Vajda S; Cornette J; DeLisi C
    Protein Sci; 1993 Nov; 2(11):1827-43. PubMed ID: 7505681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules.
    Bouvier M; Wiley DC
    Science; 1994 Jul; 265(5170):398-402. PubMed ID: 8023162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of the structure of empty and peptide-loaded major histocompatibility complex molecules at the cell surface.
    Catipović B; Talluri G; Oh J; Wei T; Su XM; Johansen TE; Edidin M; Schneck JP
    J Exp Med; 1994 Nov; 180(5):1753-61. PubMed ID: 7525837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of the human class I histocompatibility antigen, HLA-A2.
    Bjorkman PJ; Saper MA; Samraoui B; Bennett WS; Strominger JL; Wiley DC
    Nature; 1987 Oct 8-14; 329(6139):506-12. PubMed ID: 3309677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computation of the binding of fully flexible peptides to proteins with flexible side chains.
    Desmet J; Wilson IA; Joniau M; De Maeyer M; Lasters I
    FASEB J; 1997 Feb; 11(2):164-72. PubMed ID: 9039959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface.
    Buslepp J; Zhao R; Donnini D; Loftus D; Saad M; Appella E; Collins EJ
    J Biol Chem; 2001 Dec; 276(50):47320-8. PubMed ID: 11584024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. H-2Dd exploits a four residue peptide binding motif.
    Corr M; Boyd LF; Padlan EA; Margulies DH
    J Exp Med; 1993 Dec; 178(6):1877-92. PubMed ID: 8245770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.